Armitage Associates is reportedly preparing to sell its healthcare software business, MYP Corporation, after nearly five years of ownership. The boutique investment firm has appointed Houlihan Lokey ...
Everest Metals (ASX:EMC) has secured full regulatory approval to commence mining operations at its Mt Dimer Taipan Gold & Silver Project in Q4. The Western Australia Department of Mines, Petroleum and ...
Bitcoin (CRYPTO:BTC) mining hardware has seen rapid advancements in recent years, with machines now reaching over one petahash per second (PH/s) in processing power. At the World Digital Mining Summit ...
Lotus Resources (ASX:LOT) has received the environmental and social impact assessment certificate for its Kayelekera Uranium Project in Malawi. The certificate, issued to its 85%-owned subsidiary, ...
Minerals 260 (ASX:MI6) has appointed John Dermody as COO and Russell Brooks as Chief Development Officer, bolstering its executive leadership as the company accelerates development of the Bullabulling ...
Native Mineral Resources (ASX:NMR) has been granted a new Exploration Permit for Minerals (EPM 28847 – Wrotham) by Queensland's Department of Natural Resources, Manufacturing and Regional and Rural ...
BrainsWay (NASDAQ:BWAY), a global leader in noninvasive neurostimulation for mental health disorders, has revealed preliminary findings from a multicenter, randomized controlled trial demonstrating ...
Zebec Network (CRYPTO:ZBCN) has acquired compliance platform Gatenox in an all-cash deal to integrate regulatory tools into its Web3 payment infrastructure. The acquisition will embed Know Your ...
Lakes Blue Energy completed its capital consolidation process. The consolidation merged every one thousand fully paid ordinary shares into one share. Post-consolidation, Lakes Blue Energy now has ...
Latrobe Magnesium (ASX:LMG) has secured $6.3 million in funding to support the restart of its demonstration plant. The funding includes $2.8 million raised through an institutional placement and $0.75 ...
Economist Peter Schiff has issued a stark warning about the potential economic consequences of President Donald Trump's tariff policies, predicting a devastating impact on the U.S. retail sector and a ...
Invex Therapeutics (ASX:IXC) has received orphan drug designation (ODD) from the European Medicines Agency for Exenatide in the treatment of moderate to severe Traumatic Brain Injury (TBI). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results